Can the molecular typing of the specific adenohypophyseal hormone genes be useful in the management of pituitary neuroendocrine tumours?

Moragrega, Raquel Miralles; García‐Martínez, Araceli; Picó, Antonio; Aranda, Ignacio; Villaplana, Carlos R. Argente

doi:10.1016/j.endinu.2019.01.003

Cited by 1 publication

(1 citation statement)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Moreover, the protein expression of a specific gene is sometimes aborted, reducing the sensitivity of IHC in identifying the cellular origin of the tumor. Indeed, we recently reported that molecular analysis contributed to the typification of a cystic prolactinoma whose pathological study was negative for all pituitary hormones [39]. Therefore, we believe that the molecular determination of the pituitary-specific transcription factor and hormone genes significantly complements the IHC study, expanding the number of Pituitary Centers of Excellence that could benefit from a better typification of PitNETs.…”

Section: Discussionmentioning

confidence: 95%

How Valuable Is the RT-qPCR of Pituitary-Specific Transcription Factors for Identifying Pituitary Neuroendocrine Tumor Subtypes According to the New WHO 2017 Criteria?

Quesada

García‐Martínez

Silva-Ortega

et al. 2019

Cancers

Self Cite

View full text Add to dashboard Cite

The classification of pituitary neuroendocrine tumors (PitNETs) subtypes continues generating interest. In 2017, the World Health Organization (WHO) proposed considering the immunohistochemical (IHC) analysis of pituitary-specific transcription factors (TF) for their typification. The present study targeted the quantification of pituitary-specific TF (TPIT, PIT-1, SF-1, GATA2, ESR1) gene expression by RT-qPCR to overcome the shortcomings of IHC and to complement it. We analyzed 251 tumors from our collection of PitNETs and performed additional IHC studies in a subset of 56 samples to analyze the concordance between gene and protein expression of the TF. The molecular and IHC studies allowed us to significantly reduce the percentage of null cell tumors in our series, most of which were reclassified as gonadotroph tumors. The concordance between the molecular and the immunohistochemical studies was good for tumors coming from the corticotroph and Pit-1 lineages but worsened for the rest of the tumors. Indeed, the RT-qPCR helped to improve the typification of plurihormonal Pit-1 and unusual tumors. Overall, our results suggest that the RT-qPCR of pituitary-specific TF and hormone genes could help pathologists, endocrinologists, and neurosurgeons to improve the management of patients with pituitary tumors.

show abstract

Section: Discussionmentioning

confidence: 95%